IP Library Granted Patent US 12,023,276
Granted Patent B2
US 12,023,276 · App. 18/278,538 · Granted Jul 2, 2024

Intracanalicular depot inserter device

Inventors: Peter Jarrett (Burlington, MA); Erik Wong (Newton, MA)
Assignee: OCULAR THERAPEUTIX, INC.
A61F9/0017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,023,276
App. No.
18/278,538
Granted
Jul 2, 2024
Kind
B2
Abstract

Disclosed in certain embodiments is an intracanalicular injectable applicator device includes a body forming a cavity and a cannula coupled to a first distal end of the body. The cannula forms a channel that is aligned with the cavity of the body. The cannula is configured to store an intracanalicular injectable in the channel. The intracanalicular injectable applicator device further includes a tip structure coupled to the body. The tip structure is disposed around at least a portion of the cannula. A distal end of the tip structure is configured to dilate a lacrimal punctum by inserting the distal end of the tip structure into the canaliculus via the lacrimal punctum. The intracanalicular injectable applicator device further includes an actuating structure configured to push the intracanalicular injectable through the channel and the distal end of the tip structure into a canaliculus via a lacrimal punctum.

Claims (27)

1. An intracanalicular injectable applicator device comprising:

a body forming a cavity;

a cannula coupled to a first distal end of the body, wherein the cannula forms a channel that is aligned with the cavity of the body, and wherein the cannula is configured to store an intracanalicular injectable in the channel;

a tip structure coupled to the body, wherein the tip structure is disposed around at least a portion of the cannula, wherein a distal end of the tip structure is configured to dilate a lacrimal punctum by inserting the distal end of the tip structure into a canaliculus via the lacrimal punctum, the distal end of the tip structure further comprising a Shore A durometer of about 50 to about 120, and wherein an opening of the distal end of the tip structure has a diameter that is smaller than the outer diameter of an intracanalicular injectable; and

an actuating structure configured to push the intracanalicular injectable through the channel and the distal end of the tip structure into the canaliculus via the lacrimal punctum while the distal end of the tip structure is inserted into the canaliculus via the lacrimal punctum.

2. The intracanalicular injectable applicator device of claim 1 , wherein the actuating structure comprises:

a plunger structure configured to be disposed at least partially in the cavity of the body, wherein a first distal end of the plunger structure is configured to receive a force to cause actuation of the actuating structure; and

a push-wire, wherein a first distal end of the push-wire is attached to a second distal end of the plunger structure, wherein a second distal end of the push-wire is disposed in the channel of the cannula prior to the actuation of the actuating structure, wherein the push-wire is configured to push the intracanalicular injectable through the channel responsive to the actuation of the actuating structure.

3. The intracanalicular injectable applicator device of claim 2 , wherein the plunger structure comprises hooked clips configured to insert into corresponding recesses formed by an outer surface of the body to prevent the plunger structure and the body from separating and to constrain movement of the intracanalicular injectable in the cannula.

4. The intracanalicular injectable applicator device of claim 2 , wherein:

a portion of the plunger structure disposed in the cavity of the body has a non-circular perimeter;

a portion of the cavity of the body has a non-circular profile that corresponds to the non-circular perimeter; and

the actuating structure is to be rotated to align the non-circular perimeter of the portion of the plunger structure with the non-circular profile of the portion of the cavity of the body to actuate the actuating structure.

5. The intracanalicular injectable applicator device of claim 2 , wherein the cannula is affixed to the body via adhesion or insert molding, wherein the second distal end of the plunger structure forms a slot, wherein the push-wire is adhered or insert molded into the slot.

6. The intracanalicular injectable applicator device of claim 2 , wherein the cavity of the body and an outer profile of the plunger structure are tapered to direct the push-wire into the cannula.

7. A method of treatment of administering an intracanalicular injectable, the method comprising:

loading the intracanalicular injectable into a channel formed by a cannula of an intracanalicular injectable applicator device, wherein the channel is aligned with a cavity formed by a body of the intracanalicular injectable applicator device;

inserting a distal end of a tip structure of the intracanalicular injectable applicator device into a canaliculus via a lacrimal punctum to dilate the lacrimal punctum, wherein the tip structure has a Shore A durometer of about 50 to about 120, and wherein an opening of the distal end of the tip structure has a diameter that is smaller than an outer diameter of the intracanalicular injectable; and

actuating an actuating structure of the intracanalicular injectable applicator device to inject the intracanalicular injectable through the channel and the distal end of the tip structure into the canaliculus via the lacrimal punctum while the distal end of the tip structure is inserted into the canaliculus via the lacrimal punctum.

8. The method of claim 7 further comprising rotating the actuating structure to align a non-circular perimeter of the actuating structure with a corresponding non-circular profile of the cavity of the body prior to the actuating of the actuating structure.

9. The method according to claim 7 , wherein the intracanalicular injectable comprises travoprost, cyclosporine or dexamethasone.

10. A method of treatment of administering an intracanalicular injectable, the method comprising:

inserting a distal end of a tip structure of an intracanalicular injectable applicator device into a canaliculus via a lacrimal punctum to dilate the lacrimal punctum, wherein an intracanalicular injectable is loaded into a channel formed by a cannula of the intracanalicular injectable applicator device, wherein the channel is aligned with a cavity formed by a body of the intracanalicular injectable applicator device; and

actuating an actuating structure of the intracanalicular injectable applicator device to inject the intracanalicular injectable through the channel and the distal end of the tip structure into the canaliculus via the lacrimal punctum while the distal end of the tip structure is inserted into the canaliculus via the lacrimal punctum,

wherein the tip structure has a Shore A durometer of about 50 to about 120, and wherein an opening of the distal end of the tip structure has a diameter that is smaller than an outer diameter of the intracanalicular injectable.

11. The method of claim 10 further comprising rotating the actuating structure to align a non-circular perimeter of the actuating structure with a corresponding non-circular profile of the cavity of the body prior to the actuating of the actuating structure.

12. The method of claim 10 , wherein the intracanalicular injectable comprises travoprost, cyclosporine or dexamethasone.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2023
From: JARRETT, PETER; WONG, ERIK
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 064968/0805 →
Continuity (3)
Provisional Application 63250170 · Sep 29, 2021
Provisional Application 63153316 · Feb 24, 2021
Related Publication 20240082054A1 · Mar 14, 2024